Your session is about to expire
← Back to Search
Tele-consult Program
Palliative Care Tele-Consult for Life-Limiting Illnesses
N/A
Waitlist Available
Led By Marie A Bakitas, DNSc
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2-3 months after death of patient, if applicable
Awards & highlights
Study Summary
This trial is testing whether a culturally-based tele-consult program can improve palliative care for African American and White patients with a life-limiting illness.
Who is the study for?
This trial is for African American and White rural elders aged 55 or older with serious illnesses like cancer, heart disease, or neurodegenerative diseases. They must have a caregiver involved in their care, not be expected to die within the next year, and able to do interviews. Those already in hospice care or without a caregiver cannot join.Check my eligibility
What is being tested?
The study compares two approaches: a culturally-based palliative care program delivered through tele-consultations versus usual hospital care. It aims to see if this tailored telemedicine approach can reduce symptom burden among these patients.See study design
What are the potential side effects?
Since this trial involves non-medical interventions focusing on palliative care consultation rather than drugs or medical procedures, traditional side effects are not applicable. However, there may be emotional or psychological impacts from discussing end-of-life issues.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2-3 months after death of patient, if applicable
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2-3 months after death of patient, if applicable
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Patient symptom burden (Edmonton Symptom Assessment Scale [ESAS])
Secondary outcome measures
Caregiver burden scale (Montgomery Borgatta Caregiver Burden Scale [MBCB])
Caregiver quality of life (Patient-Reported Outcomes Measurement Information System Global Health-10 [PROMIS Global Health-10])
Family satisfaction with care (FAMCARE-2)
+3 moreOther outcome measures
Exploratory Aim 1a. Patient symptom burden (Edmonton Symptom Assessment Scale [ESAS])
Exploratory Aim 1b. Patient symptom burden (Edmonton Symptom Assessment Scale [ESAS])
Exploratory Aim 1c. Caregiver burden (Montgomery Borgatta Caregiver Burden Scale [MBCB])
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Active InterventionExperimental Treatment1 Intervention
Usual Care + Tele-consult Intervention
Group II: Usual CareActive Control1 Intervention
Usual care includes assessment and treatment by the admitting physician, along with any subspecialists that are consulted.
Find a Location
Who is running the clinical trial?
National Institute of Nursing Research (NINR)NIH
583 Previous Clinical Trials
10,376,911 Total Patients Enrolled
University of Alabama at BirminghamLead Sponsor
1,593 Previous Clinical Trials
2,282,428 Total Patients Enrolled
Marie A Bakitas, DNScPrincipal InvestigatorUniversity of Alabama at Birmingham
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are currently in hospice care.Your doctor thinks it would not be surprising if you died within the next year.It seems like the criterion "AA or W" may be incomplete or unclear. Could you provide more context or clarify what this criterion is referring to?You are 55 years old and have cancer, a long-term illness that gets worse over time, or are very weak.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care
- Group 2: Active Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities for individuals to participate in this experiment?
"Affirmative, according to the information on clinicaltrials.gov this medical research project is actively recruiting participants. Initially uploaded in August 2020, with a most recent update on October 2022, 352 patients need to be recruited from 3 separate sites."
Answered by AI
What is the cap on participant recruitment for this trial?
"Affirmative, the clinicaltrials.gov page for this research project displays that participant recruitment is currently underway. Initially posted on August 24th 2020 and recently updated on October 13th 2022, 352 participants from 3 sites are required to complete the trial."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger